• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Jeff Sutherland

  • GREATER MANCHESTER, Jan. 7, 2021 — Doris Wildgoose, 99, receives her second dose of the Pfizer-BioNTech COVID-19 vaccine at Hyde Leisure Centre in Greater Manchester, Britain, on Jan. 7, 2021. British Prime Minister Boris Johnson told MPs on Wednesday that the government will use “every available second” of the lockdown to place an “invisible shield” around elderly and vulnerable people through the rollout of COVID-19 vaccines in the coming weeks. (Photo by Jon Super/Xinhua via Getty) (Xinhua/Jon Super via Getty Images)Health

    Pfizer BioNTech vaccine may be effective against fast-spreading COVID-19 variants, study says

    By Jeff Sutherland, Jason Gale, and others
  • Coronavirus Vaccine Research at Valneva SA LabsInternational

    Pfizer says its COVID-19 vaccine is on track for regulatory review in October

    By Bloomberg and Jeff Sutherland
  • SEOUL, SOUTH KOREA - FEBRUARY 21: A medical professional is seen at a preliminary testing facility at the National Medical Center where patients suspected of contracting coronavirus (COVID-19) are assessed on February 21, 2020 in Seoul, South Korea. South Korea reported 52 new cases of the coronavirus (COVID-19) bringing the total number of infections in the nation to 156, with the potentially fatal illness spreading fast across the country. (Photo by Chung Sung-Jun/Getty Images)International

    Coronavirus epidemic enters new phase as cases outside of China spike

    By Jeff Sutherland and Bloomberg
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.